Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI
- PMID: 32877210
- PMCID: PMC7548370
- DOI: 10.1259/bjr.20200543
Manual and semi-automated delineation of locally advanced rectal cancer subvolumes with diffusion-weighted MRI
Abstract
Objectives: To evaluate interobserver agreement for T2 weighted (T2W) and diffusion-weighted MRI (DW-MRI) contours of locally advanced rectal cancer (LARC); and to evaluate manual and semi-automated delineations of restricted diffusion tumour subvolumes.
Methods: 20 cases of LARC were reviewed by 2 radiation oncologists and 2 radiologists. Contours of gross tumour volume (GTV) on T2W, DW-MRI and co-registered T2W/DW-MRI were independently delineated and compared using Dice Similarity Coefficient (DSC), mean distance to agreement (MDA) and other metrics of interobserver agreement. Restricted diffusion subvolumes within GTVs were manually delineated and compared to semi-automatically generated contours corresponding to intratumoral apparent diffusion coefficient (ADC) centile values.
Results: Observers were able to delineate subvolumes of restricted diffusion with moderate agreement (DSC 0.666, MDA 1.92 mm). Semi-automated segmentation based on the 40th centile intratumoral ADC value demonstrated moderate average agreement with consensus delineations (DSC 0.581, MDA 2.44 mm), with errors noted in image registration and luminal variation between acquisitions. A small validation set of four cases with optimised planning MRI demonstrated improvement (DSC 0.669, MDA 1.91 mm).
Conclusion: Contours based on co-registered T2W and DW-MRI could be used for delineation of biologically relevant tumour subvolumes. Semi-automated delineation based on patient-specific intratumoral ADC thresholds may standardise subvolume delineation if registration between acquisitions is sufficiently accurate.
Advances in knowledge: This is the first study to evaluate the feasibility of semi-automated diffusion-based subvolume delineation in LARC. This approach could be applied to dose escalation or 'dose painting' protocols to improve delineation reproducibility.
Figures









Similar articles
-
Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods.Br J Radiol. 2021 Mar 1;94(1119):20201174. doi: 10.1259/bjr.20201174. Epub 2021 Jan 28. Br J Radiol. 2021. PMID: 33507812 Free PMC article.
-
Gross tumour volume delineation in anal cancer on T2-weighted and diffusion-weighted MRI - Reproducibility between radiologists and radiation oncologists and impact of reader experience level and DWI image quality.Radiother Oncol. 2020 Sep;150:81-88. doi: 10.1016/j.radonc.2020.06.012. Epub 2020 Jun 12. Radiother Oncol. 2020. PMID: 32540336
-
Rectal tumour volume (GTV) delineation using T2-weighted and diffusion-weighted MRI: Implications for radiotherapy planning.Eur J Radiol. 2014 May;83(5):768-72. doi: 10.1016/j.ejrad.2014.02.007. Epub 2014 Feb 25. Eur J Radiol. 2014. PMID: 24646719
-
Volumetry of the dominant intraprostatic tumour lesion: intersequence and interobserver differences on multiparametric MRI.Br J Radiol. 2017 Mar;90(1071):20160416. doi: 10.1259/bjr.20160416. Epub 2017 Jan 5. Br J Radiol. 2017. PMID: 28055249 Free PMC article.
-
A literature review of the association between diffusion-weighted MRI derived apparent diffusion coefficient and tumour aggressiveness in pelvic cancer.Cancer Treat Rev. 2015 Jun;41(6):496-502. doi: 10.1016/j.ctrv.2015.03.010. Epub 2015 Apr 11. Cancer Treat Rev. 2015. PMID: 25892290 Review.
Cited by
-
Radiotherapy dose escalation using pre-treatment diffusion-weighted imaging in locally advanced rectal cancer: a planning study.BJR Open. 2023 Dec 12;6(1):tzad001. doi: 10.1093/bjro/tzad001. eCollection 2024 Jan. BJR Open. 2023. PMID: 38352181 Free PMC article.
-
Improved deep learning for automatic localisation and segmentation of rectal cancer on T2-weighted MRI.J Med Radiat Sci. 2024 Dec;71(4):509-518. doi: 10.1002/jmrs.794. Epub 2024 Apr 24. J Med Radiat Sci. 2024. PMID: 38654675 Free PMC article.
-
DWI-MR and PET-CT Functional Imaging for Boost Tumor Volume Delineation in Neoadjuvant Rectal Cancer Treatment.In Vivo. 2023 Jan-Feb;37(1):424-432. doi: 10.21873/invivo.13095. In Vivo. 2023. PMID: 36593016 Free PMC article.
-
The Role of MRI and PET/CT in Radiotherapy Target Volume Determination in Gastrointestinal Cancers-Review of the Literature.Cancers (Basel). 2023 May 29;15(11):2967. doi: 10.3390/cancers15112967. Cancers (Basel). 2023. PMID: 37296929 Free PMC article. Review.
-
Semi-automatic tumor segmentation of rectal cancer based on functional magnetic resonance imaging.Phys Imaging Radiat Oncol. 2022 May 11;22:77-84. doi: 10.1016/j.phro.2022.05.001. eCollection 2022 Apr. Phys Imaging Radiat Oncol. 2022. PMID: 35602548 Free PMC article.
References
-
- Burbach JPM, den Harder AM, Intven M, van Vulpen M, Verkooijen HM, Reerink O. Impact of radiotherapy boost on pathological complete response in patients with locally advanced rectal cancer: a systematic review and meta-analysis. Radiother Oncol 2014; 113: 1–9. doi: 10.1016/j.radonc.2014.08.035 - DOI - PubMed
-
- Hearn N, Atwell D, Cahill K, Elks J, Vignarajah D, Lagopoulos J, et al. . Neoadjuvant radiotherapy dose escalation in locally advanced rectal cancer: a systematic review and meta-analysis of modern treatment approaches and outcomes. Clin Oncol 2020;12 Jul 2020. doi: 10.1016/j.clon.2020.06.008 - DOI - PubMed
-
- Valentini V, Gambacorta MA, Cellini F, Aristei C, Coco C, Barbaro B, et al. . The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer. Radiother Oncol 2019; 134: 110–8. doi: 10.1016/j.radonc.2018.11.023 - DOI - PubMed